Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

( NewsNation) — Drugmaker MannKind announced that its inhaled insulin, Afrezza, has been approved for an application to help ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct.

New research presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a ...

Children receive roughly 30 vaccine doses before age 18, doctors say. Health and Human Services Secretary Robert F. Kennedy Jr. said at a Senate hearing on Thursday that children receive up to 92 ...

New Delhi: India has drawn up a plan to plug gaps in vaccination coverage, and use technology to ensure that no child is left out of its universal immunization programme. In its attempt to make the ...

WEDNESDAY, Sept. 3, 2025 (HealthDay News) -- For children with type 1 diabetes (T1D), glycated hemoglobin (HbA1c) levels are associated with accessibility of modern diabetes technologies and insulin, ...